Nomic Bio Inc., a proteomics company, and VO Health, a company developing blood-based measures of fitness and functional health, today announced that VO Health is using Nomic’s proteomics platform to ...

PMV Pharmaceuticals is rated Buy, targeting $3–$4/share, driven by Rezatapopt's 46% response rate. Click to read more about ...

AM to October 6, 7:00 AM JST. This includes materials with unknown publication or update times, as well as relevant ...

Anthropic's own alignment lead puts extinction odds above 10%. Here's what the science, resignations, and data actually say ...

A retrospective cohort of 259 Colombian breast cancer patients with germline pathogenic variants found a ten-year overall ...

Researchers tested an AI-designed drug that might be able to wind back our biological clock. Ian explains why this is such a ...

A systematic review and meta-analysis of 1,078 patients finds that interferon-free dual direct-acting antiviral therapy cures ...

An estimated 100 million Americans have metabolic dysfunction-associated steatotic liver disease, or MASLD, the condition ...

Patients and doctors are eager for a noninvasive way to diagnose the disease, and several start-ups are offering new options.

Deutsche Bank estimates Q3 organic growth of -0.5% for PFNA, down from its previous +0.5% forecast, while PepsiCo Beverages North America (PBNA) is expected to grow 1.5%. U.S. scanned-channel ...

Seattle-based Talus Bio is going after proteins that resist that approach, notably transcription factors, which control which ...

One that rewards competitors for getting younger. I recently turned 40, and I don’t need reminding that both time and my chronological age only tick forward. But this game is focused on competitors’ ...